Question 1

What are the most cited papers from OsteoGeneX (United States)?

Accepted Answer

The most cited paper from OsteoGeneX (United States) is "Bone Density Ligand, Sclerostin, Directly Interacts With LRP5 but Not LRP5G171V to Modulate Wnt Activity" (Debra L. Ellies, Beth L. Viviano, John Joseph McCarthy et al., 2006), with 355 citations. Next come "In vivo mechanical loading rapidly activates β-catenin signaling in osteocytes through a prostaglandin mediated mechanism" (136) and "Wnt modulators in the biotech pipeline" (71).

Question 2

Which research topics does OsteoGeneX (United States) publish most on?

Accepted Answer

By volume: Animal Genetics and Reproduction, Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation and Skin and Cellular Biology Research.

Question 3

Which fields of science does OsteoGeneX (United States) work in?

Accepted Answer

In all years, 96% of research at OsteoGeneX (United States) is in Life Sciences, 4% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (96%), Medicine (4%). It does 1.6× the world's share of Life Sciences.